ClinicalTrials.Veeva

Menu

Comparison of Two D-Dimers Dosing Techniques (COMPADDI)

R

Regional University Hospital Center (CHRU)

Status

Completed

Conditions

Blood Coagulation Disorder

Study type

Observational

Funder types

Other

Identifiers

NCT03972839
29BRC19.0034

Details and patient eligibility

About

Study of the possibility of substitution of the automated STAGO D-Dimers method with the semi-automated VIDAS method, which is more expensive, longer to implement and requires the use of a dedicated automaton.

Full description

To compare D-Dimer assay techniques in the exclusion of VTE (Thromboembolic Venous Disease):• BIOMERIEUX: D-Dimers VIDAS (considered as reference technique)• STAGO: D-Di PlusOn a population of patients recruited in Brest for a period of 1 year: patients for whom a dosage of VIDAS D-dimers is prescribed (approximately 3700 patients)

Enrollment

3,027 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients for whom a dosage of D-Dimers VIDAS is prescribed in the context of a suspicion of VTE at Brest CHRU.
  • No opposition formulated.

Exclusion criteria

  • Curative dose anticoagulant treatment whatever the indication,
  • Pregnancy in progress,
  • Follow-up at 3 months not possible,
  • Patient refusing to participate

Trial design

3,027 participants in 1 patient group

D-Dimers patients
Description:
population recruited in Brest for a period of 1 year: patients for whom a dose of VIDAS D-dimers is prescribed (approximately 3700 patients)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems